Tech Company Financing Transactions
Alto Pharmacy Funding Round
On 2/6/2020, Alto Pharmacy raised $250 million in Series D funding from SoftBank Vision Fund, Greenoaks Global and Jackson Square Ventures.
Transaction Overview
Company Name
Announced On
2/6/2020
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Series D
Investors
SoftBank Vision Fund (Lead Investor) (Justin Wilson)
Greenoaks Global (Neil Shah)
Proceeds Purpose
The funding aims to support Alto's geographic expansion across the United States and product development.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
1400 Tennessee St. 2
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Our mission is to be the world's most patient-centric pharmacy, where patients get the care they deserve. We use technology and empathy to advance the pharmacy into the modern era and make high-quality healthcare accessible to all. The modern pharmacy is not a mere distributor of medication, but the central hub of a new healthcare platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mattieu Gamache-Asselin
Chief Financial Officer
Brian Meewes
Chief Medical Officer
Amil Patel
Chief Operating Officer
Jessica Jalsevac
Chief Technical Officer
Jamie Karraker
VP - Bus. Development
Melissa Miao
VP - Product Management
Monica Tran
VP - Sales
Craig Thompson
Browse more venture capital transactions:
Prev: 2/6/2020: Lightning Labs venture capital transaction
Next: 2/6/2020: A.Team venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs